Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
NXNexalin Technology, Inc. logo

Nexalin Technology, Inc. (NXL)

NASDAQ Capital Market · Currency in USD
$1.86 ▼ -0.17 (-8.37%)
At close: Oct 23, 4:00 PM ET. Market closed.
$1.93 ▲ +0.07 (+3.76%)
After hours: Oct 23, 7:39 PM ET

Summary

Previous Close
$2.03
Open
$2.03
Day's Range
$1.86 – $2.07
52 Week Range
$1.86 – $49.50
Volume
25,366
Avg. Volume
18,344
Market Cap
$1.36M
Beta (5Y Monthly)
4.11
PE Ratio (TTM)
--
EPS (TTM)
-$12.75
Earnings Date
Nov 13, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Nexalin Technology, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
8
CEO
Mark White

Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders.

Earnings

Next report: Fri, Nov 13, 2026
EPS estimate -$2.91 · Revenue est. $75.00K
DateEst.Actual
Aug 12, 2026-$3.00-$3.30Miss
May 8, 2026-$3.00-$0.11Beat
Mar 25, 2026-$0.12-$0.13Miss
Nov 14, 2025-$0.12-$0.13Miss
Aug 6, 2025-$0.10-$0.10Beat
May 13, 2025-$0.15-$0.15Beat

Analyst view

Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on NXL and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.